Breaking the myth: opioids provide no advantage for acute back pain, study finds

FHS
July 3, 2023
3:10 pm

The first placebo-controlled trial of opioids in acute low back and neck pain.

First clinical study results of psilocybin treatment in anorexia nervosa published in Nature Medicine | Psychedelic Invest

COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the publication of a

July 25, 2023

ONC Launches Platform for Organizing and Building USCDI+ Datasets

What You Should Know: – Today, the Office of the National Coordinator for Health Information Technology (ONC) has officially launched a new platform dedicated to

December 7, 2023

Researchers develop a potential one-minute COVID-19 test inspired by bioluminescence

Cold, flu and COVID-19 season brings that now-familiar ritual: swab, wait, look at the result. But what if, instead of taking 15 minutes or more,

January 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.